Vertaling van "international congress tropical medicine " (Engels → Frans) :

TERMINOLOGIE

Canadian Society for International Health [ CSIH | Canadian Society for Tropical Medicine and International Health | Tropical Medicine and International Health Division ]
Société canadienne de santé internationale [ SCSI | Société canadienne pour la médecine tropicale et la santé internationale | Division de médecine tropicale et de santé internationale ]

International Congress for Tropical Medicine and Malaria [ ICTMM | International Congress of Tropical Medicine | International Congress on Malaria | International Society for Tropical Medicine ]
Congrès international de médecine tropicale et de paludisme [ CIMTP | Congrès international de médecine tropicale ]

International Committee of Military Medicine [ ICMM | International Committee of Military Medicine and Pharmacy | Standing Committee for International Congresses of Military Medicine and Pharmacy ]
Comité International de Médecine Militaire [ CIMM | Comité international de médecine et de pharmacie militaires | Comité permanent des congrès internationaux de médecine et de pharmacie militaires ]

International Congress on Tropical Medecine and Malaria | ICTMM [Abbr.]
Congrès international de médecine tropicale et de paludisme | CIMTP [Abbr.]

International Tropical Pediatrics Congress
Congrès international de pédiatrie tropicale

IN-CONTEXT TRANSLATIONS

The Observatory is a partnership project of the World Health Organisation Regional Office for Europe, the governments of Belgium, Finland, Norway, Slovenia, Spain and Sweden, the Veneto Region of Italy, the European Commission (throughout the duration of the health programme, 2009-2013), the European Investment Bank (EIB), the International Bank for Reconstruction and Development (World Bank), the French Union of Healthcare Funds (UNCAM), London School of Economics (LSE) and the London School for Hygiene and Tropical Medicine (LSHTM).
L’Observatoire est un projet mené en partenariat par le bureau régional de l’Organisation mondiale de la santé pour l’Europe, les gouvernements de Belgique, de Finlande, de Norvège, de Slovénie, d’Espagne et de Suède, la région italienne de Vénétie, ainsi que la Commission européenne (pendant la durée du programme de santé, 2009-2013), la Banque européenne d’investissement (BEI), la Banque internationale pour la reconstruction et le développement (Banque mondiale), l’Union nationale française des caisses d’assurance-maladie (UNCAM), la London School of Economics (LES) et la London School for Hygiene and Tropical Medicine (LSHTM).

- having regard to the European and Developing Countries Clinical Trials Partnership (EDCTP), Special Programme for Research and Training in Tropical Diseases (TDR), Global Alliance for TB Drug Development (TB Alliance), International AIDS Vaccine Initiative (IAVI), International Partnership for Microbicides (IPM), European Malaria Vaccine Initiative (EMVI), GAVI (Global Alliance for Vaccines and Immunization)/The Vaccine Fund, Medicines for Malaria Venture (MMV), Roll Back Malaria (RBM) Partnership and the Drugs for Neglected Diseases Initiative (DNDi) and others who are working to research and develop drugs for neglected diseases,
– vu les initiatives suivantes: European and Developing Countries Clinical Trials Partnership (EDCTP), Special Programme for Research and Training in Tropical Diseases (TDR), Global Alliance for TB Drug Development (TB Alliance), International AIDS Vaccine Initiative (IAVI), International Partnership for Microbicides (IPM), European Malaria Vaccine Initiative (EMVI), GAVI (Global Alliance for Vaccines and Immunization)/The Vaccine Fund, Medicines for Malaria Ventures (MMV), Roll Back Malaria (RBM) Partnership, Drugs for Neglected Diseases Initiative (DNDi), et autres associations qui œuvrent dans le domaine de la recherche et du développement de médicaments destinés à lutter contre les maladies négligées,

Of a total of 1 450 new medicinal products which came on to the market between 1972 and 1997, only 13 were specially designed for the treatment of tropical diseases and designated essential drugs (Tropical Medicine and International Health, Volume 4, Issue 6, p. 412).
C'est ainsi que sur 1 450 nouveaux médicaments qui ont été mis sur le marché de 1972 à 1997, seuls 13 étaient spécifiquement destinés à traiter les maladies tropicales et avaient un statut de médicament essentiel (Tropical Medicine and International Health, volume 4, n° 6, p. 412).

Of 1450 new medicines marketed between 1972 and 1997, only 13 were specifically for tropical diseases and considered as essential drugs (Tropical Medicine and International Health, Volume 4, no 6 p. 412).
Sur les 1 450 nouveaux médicaments commercialisés entre 1972 et 1997, seuls treize médicaments étaient spécifiquement consacrés aux maladies tropicales et qualifiés de médicaments essentiels (Tropical Medicine and International Health, volume 4, n 6, p. 412).

We are pleased this morning to have as witnesses, from the Canadian Council of International Co-operation, Mr. Gerry Barr, president; from Development and Peace, Mary Durran, researcher; from the Canadian Labour Congress, Monsieur Pierre Laliberté; from the Canadian Foodgrains Bank, Stuart Clark, senior policy adviser; from Doctors Without Borders, Carol Devine, access to essential medicines liaison; and from Oxfam Canada, Mark Fried.
Nous avons le plaisir, ce matin, d'accueillir comme témoins M. Gerry Barr, président du Conseil canadien pour la coopération internationale, Mme Mary Durran, recherchiste de Développement et paix, M. Pierre Laliberté, du Congrès du travail du Canada, M. Stuart Clark, conseiller principal en politiques à la Banque de céréales vivrières du Canada, Mme Carol Devine, Liaison pour l'accès aux médicaments essentiels de Médecins sans frontières, et M. Mark Fried, d'Oxfam Canada.